Journal profile · Pathology

Disease Markers

ISSN 0278-0240 · eISSN 1875-8630 · Hindawi Limited · NETHERLANDS · Bimonthly · Founded 1983

Disease Markers: impact factor 2.1; fully open access; APC about USD 2,550; review 6–12 weeks (community reports); community-reported acceptance: fairly easy; 19 articles in 2025; indexed in Scopus; flagged on an early-warning list or for an indexing change: check before submitting.

Impact factor2.1Latest value listed by LetPub
CAS zone—Not in the CAS Journal Ranking
Review time6–12 weeksCommunity average
APCUSD 2,550Fully open access
AcceptanceFairly easyCommunity average
Articles per year192025 · OpenAlex count

Scope

Aims, scope and focus

Disease Markers is published by Hindawi Limited. By OpenAlex counts of its recent articles, its largest topics are Cancer-related molecular mechanisms research, Ferroptosis and cancer prognosis and MicroRNA in disease regulation, together about 29.7% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)

Disease Markers is a peer-reviewed, open access journal that publishes original research articles and review articles related to the identification of disease markers, the elucidation of their role and mechanism, as well as their application in the prognosis, diagnosis and treatment of diseases.

From the journal's Aims & Scope

Research area (LetPub): Pathology

Editor-in-chief Paola GazzanigaPublisher website

Editorial board by country: 25 in mainland China (about 19%); most named Italy 31, United States 27, Mainland China 25, Greece 6, India 5 (133 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology11.2%
  2. Ferroptosis and cancer prognosisMedicine9.9%
  3. MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology8.6%
  4. RNA modifications and cancerBiochemistry, Genetics and Molecular Biology6.4%
  5. Circular RNAs in diseasesBiochemistry, Genetics and Molecular Biology6.2%
  6. Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology4.7%
  7. Liver Disease Diagnosis and TreatmentMedicine4.1%
  8. Inflammatory Biomarkers in Disease PrognosisMedicine4%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ScopusLetPub

Early warning / risk: Removed from SCIE on 20 March 2023. CAS Early Warning Journal List: not listed in any of 6 editions.LetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
2.1LetPub ·
CiteScore 2026-06
3.7LetPub ·
SJR 2026-06
0.66LetPub ·
SNIP 2026-06
0.75LetPub ·
h-index
58LetPub ·
h-index
99OpenAlex ·
i10-index
2,296OpenAlex ·
2-year mean citedness
1.03OpenAlex ·
Share of gold OA articles
98.83%LetPub ·

Volume

Articles per year
241LetPub ·

Articles by year OpenAlex count · 4,071 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026870
202519180
2024111039
2023216216512
20228378368,021
20213343324,621

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
6–12 weeksLetPub ·
Average acceptance (community reports)
Fairly easyLetPub ·
Peer review
Blind peer reviewLetPub

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessLetPub

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
OpenAlexUSD 2,550——
LetPubUSD 2,300Yes—

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare3 items from the author guidelines
Abstract
≤ 300 words
Reference style
Chicago
First submission
Free format: the journal's layout is not required
Publisher website · model-extracted, each line checked against the text
Article types accepted7
  1. original researchThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
  2. research articleThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
  3. research articlesResearch articles should present the results of an original research study. These manuscripts should describe how the research project was conducted and provide…Length not stated
  4. reviewThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
  5. review articleThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
  6. reviewsA review article provides an overview of the published literature in a particular subject area.Length not stated
  7. systematic reviewThe journal will consider the following article types: Research articles Research articles should present the results of an original research study. These manus…Length not stated
Publisher website
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, License & copyright, Peer review, Plagiarism, Preprints, Trial registration / reporting guidelines
Authorship Title and authorship information

The following information should be included: Manuscript title Full author names Full institutional mailing addresses Email addresses Affiliations. The publisher remains neutral with regard to jurisdictional claims in institutional affiliations. Responsibility for affiliations ultimately rests with the author, although the publisher may request changes be made to countries listed in affiliations t…

Source ↗Publisher website ·
Conflicts of interest Conflicts of interest

Concurrent submissions limited to three manuscripts under review Model summary

Authors must declare all relevant interests that could be perceived as conflicting. Authors should explain why each interest may represent a conflict. If no conflicts exist, the authors should state this. Submitting authors are responsible for co-authors declaring their interests. Conflicts of interest (COIs, also known as 'competing interests') occur when issues outside research could be reasonab…

Source ↗Publisher website ·
Data availability Data availability

Data availability statement required Model summary

Authors must include a data availability statement with their submission. When submitting a manuscript, submitting authors will be asked to select from several pre-written statements or use the text editor to tell us about data availability with regard to their submission. Review our Data Sharing Policy to understand which data availability statement is right for your submission.

Source ↗Publisher website ·
License & copyright Copyright and permissions

Copyright: authors retain copyright, CC BY license Model summary

Authors retain the copyright of their manuscripts, and all open access articles are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not speci…

Source ↗Publisher website ·
Peer review Peer review

Peer review model: single-anonymized Model summary

The journal follows a single-anonymized peer review model, for applicable article types. Information on the Peer Review model can be found here. Wiley's policy on the confidentiality of the review process is available here. All submitted articles are subject to assessment and peer review to ensure editorial appropriateness and technical correctness. Research published in the journal must be: Scien…

Source ↗Publisher website ·
Plagiarism

Plagiarism screening via iThenticate CrossCheck Model summary

This journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts.

Source ↗Publisher website ·
Preprints Preprints

Preprint policy: preprint servers allowed Model summary

The journal accepts articles previously published on preprint servers, and does not consider this to compromise the novelty of the results. Articles based on content previously made public only on a preprint server, institutional repository, or in a thesis will be considered. The preprint should be cited.

Source ↗Publisher website ·
Trial registration / reporting guidelines Reporting guidelines

Authors are strongly encouraged to use appropriate reporting guidelines when preparing and submitting manuscripts, to maximize transparency and reproducibility. Our editors and reviewers are also encouraged to use them in the review process. Completed checklists should be provided in the supplementary files on submission. We particularly encourage the use of: CONSORT for randomized controlled tria…

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Hindawi Limited
Country or region
NETHERLANDS
Language
English
Frequency
Bimonthly
Founded
1983
ISSN
0278-0240
Electronic ISSN
1875-8630
Official links

FAQ

Frequently asked questions about Disease Markers

What is the impact factor of Disease Markers?

The latest impact factor listed by LetPub is 2.1; CiteScore 3.7, h-index 99.

How long does peer review take at Disease Markers?

Authors report an average review time of 6–12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

What are the manuscript requirements of Disease Markers?

According to the journal's author guidelines: Abstract: ≤ 300 words; Reference style: Chicago; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.

Where are the editorial board members of Disease Markers based?

Of the 133 board members whose country the journal's board page names, 25 (about 19%) are in mainland China; the countries named most often are Italy (31), United States (27) and Mainland China (25). Counted from the institutions listed on the board page; for reference only.

Which databases index Disease Markers?

According to LetPub and DOAJ records, Disease Markers is indexed in Scopus.

Is Disease Markers open access, and what is the APC?

Disease Markers is a fully open-access journal. APC about USD 2,550.

Sources and updates

The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .